Ally Pharma US Executes Merger
(firmenpresse) - TAMPA, FL -- (Marketwired) -- 12/04/14 -- Ally Pharma US, Inc. (OTCBB: ALPHD) today announced that it completed a merger on September 30, 2014 with TPT Global Tech, Inc., a San Diego, California-based technology company.
The new direction of the company will be focused on communications and technology domestically and internationally. TPT Global Tech, Inc., will be under the direction of its new CEO, Mr. Stephen J. Thomas III.
For additional information about TPT Global Tech, Inc., please contact .
Ally Pharma US, Inc. (OTCBB: ALPHD) operates as a development stage biopharmaceutical company primarily in the United States. It focuses on the acquisition, licensing, and commercialization of pharmaceutical products and technologies, as well as homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, autoimmune, and infectious diseases.
The company is based in Tampa, Florida.
Marla Ellerman
MSE Marketing
6025158808
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 04.12.2014 - 10:41 Uhr
Sprache: Deutsch
News-ID 1323157
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
TAMPA, FL
Phone:
Kategorie:
Biotech
Anmerkungen:
Diese Pressemitteilung wurde bisher 112 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Ally Pharma US Executes Merger
"
steht unter der journalistisch-redaktionellen Verantwortung von
Ally Pharma US (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
